No Data
US Stock MarketDetailed Quotes
ORTX Orchard Therapeutics
Watchlist
6.9700
-0.1750-2.45% Close 09/22 16:00 ET
6.97000.00000.00%
Post 16:08 ET
7.1700High6.8700Low78.70KVolume
7.1600Open7.1450Pre Close553.86KTurnover0.69%Turnover RatioLossP/E (TTM)158.38MMarket Cap7.250052wk HighLossP/E (Static)22.72MShares3.601052wk Low1.45P/B79.57MFloat Cap216.4000Historical High--Dividend TTM11.42MShs Float3.6010Historical Low--Div YieldTTM4.20%Amplitude7.0370Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Orchard Therapeutics Company
Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom.
Revenue Breakdown
Business
Unit:USD
Stock NameYOYOperating income%
Libmeldy--18.8M82.97%
Collaboration revenue--2.05M9.03%
Strimvelis--1.81M8.01%
News
Comments
NEWS!
$Orchard Therapeutics(ORTX.US$ BOSTON and LONDON, September 18, 2023, (GLOBE NEWSWIRE) – Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced the U.S. Food and Drug Administration (FDA) has accepted the filing of its Biologics License Application (BLA) for OTL-200 in metachromatic leukodystrophy (MLD) under Priority Review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of March 18, 2024. “Today is another significant step forward for pa...
1
Huge price target change
$Orchard Therapeutics(ORTX.US$ Orchard Therapeutics Stock Price Target Raised to $22 From $4 at Stifel Nicolaus. Oppenheimer raises it to $32. Its going to run up soon. Needs to break 5.38 to continue uptrend.
6
1
$Orchard Therapeutics(ORTX.US$ got in early jn, then stopped out as it dropped to 0.62... how unlucky. thought the float size was large but apparently all penny healthcare stocks run now
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--